darolutamide 300 MG Oral Tablet

RxCUI: 2180330
RxNorm name: darolutamide 300 MG Oral Tablet
Display name: darolutamide 300 MG Oral Tablet
Full name: darolutamide 300 MG Oral Tablet
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NUBEQA	DAROLUTAMIDE	Bayer HealthCare Pharmaceuticals Inc.	1a7cb212-56e4-4b9d-a73d-bfee7fe4735e	2025-06-03	Warnings, Adverse reactions	Exact identifier rxcui: 2180330

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
1a7cb212-56e4-4b9d-a73d-bfee7fe4735e	darolutamide 300 MG Oral Tablet	SCD	23	These highlights do not include all the information needed to use NUBEQA safely and effectively. See full prescribing information for NUBEQA. NUBEQA ® (darolutamide) tablets, for oral use Initial U.S. Approval: 2019	20250603
1a7cb212-56e4-4b9d-a73d-bfee7fe4735e	darolutamide 300 MG Oral Tablet	PSN	23	These highlights do not include all the information needed to use NUBEQA safely and effectively. See full prescribing information for NUBEQA. NUBEQA ® (darolutamide) tablets, for oral use Initial U.S. Approval: 2019	20250603